TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02591485

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Control Training
Description: In the ACT, participants perform six computerized attention training sessions, 10 minutes per training session over six weeks. In each session the dot-probe task is administered. This task is consisted of 160 trials. Each trial began with a centrally-presented fixation cross that then replaced by a pair of words presented. Following that, a target probe appeared in the location previously occupied by one of the words, and participants are requested to discriminate the probe type via button press. Targets appear with equal probability at the location of threat and neutral stimuli, in order to modify the fluctuations in attention allocation.
Study: NCT03842449

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: BabyCO
Description: An expired CO measurement will be performed by BabyCO and the result will be returned to the smoking pregnant woman by the consultant.
Study: NCT03131440

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App notifications
Description: Participants will receive motivational app notifications

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App notifications
Description: Participants will receive motivational app notifications

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App notifications
Description: Participants will receive motivational app notifications

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App notifications
Description: Participants will receive motivational app notifications

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App notifications
Description: Participants will receive motivational app notifications

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Study: NCT02166723

Intervention type: DEVICE
Intervention: Cryoballoon Ablation
Description: . The goal was to isolate all 4 veins with application of cryoballoon on the ostium of the vein. A 28 mm balloon was used with centrifugal cooling system. The maximum temperature reached was between -45 C and -60 C to optimize irreversible isolation without causing extracardiac complications. A circular catheter (Achieve) was used to map electrograms in conjunction with the NavX ENSITE 3000, St Judes . Intracardiac ultrasound was used to measure the pulmonary vein diameter, check for intraoperative complications, determine complete occlusion of the vein by the balloon and guide transeptal puncture. . In each patient the left atrium was debulked by applying cryoballoon

Intervention type: DEVICE
Intervention: cryoballoon ablation
Description: A 28 mm balloon was used with centrifugal cooling system. The maximum temperature reached was between -45 C and -60 C to optimize irreversible isolation without causing extracardiac complications. A circular catheter (Achieve) was used to map electrograms in conjunction with the NavX ENSITE 3000, St Judes . Intracardiac ultrasound was used to measure the pulmonary vein diameter, check for intraoperative complications, determine complete occlusion of the vein by the balloon and guide transeptal puncture. In each patient the left atrium was debulked by applying cryoballoon to the left and right sides of the left atrial roof and cryoablation of the left lateral ridge from within the left atrial appendage.
Study: NCT03596775

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Children in Dexmedetomidine group receive intravenous dexmedetomidine 0.5 ug/kg over 10 minutes after induction of anesthesia.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: saline
Description: Children in Control Comparator group receive intravenous saline 10ml over 10 minutes after induction of anesthesia.
Study: NCT03991052

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EV1000 and closed-loop system
Description: This system will recommend when patients need fluid or not and adjust vasopressor administration automatically by the closed-loop system
Study: NCT03842449

Intervention type: OTHER
Group type: OTHER
Intervention: Biological samples
Description: The nature of the samples taken during the delivery are:~* maternal blood,~* cord blood~* placenta fragment

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biological samples
Description: The nature of the samples taken during the delivery are:~* maternal blood,~* cord blood~* placenta fragment

Intervention type: OTHER
Group type: OTHER
Intervention: Biological samples
Description: The nature of the samples taken during the delivery are:~* maternal blood,~* cord blood~* placenta fragment
Study: NCT05270564

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Drain
Description: Surgical drains are placed as a standard of care (control arm) or not (experimental arm)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No drain
Description: Surgical drains are placed as a standard of care (control arm) or not (experimental arm)
Study: NCT01408953

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bevacizumab
Description: Bevacizumab will be diluted with 0.9% Sodium Chloride to achieve a concentration of 1 mg/0.3 ml. Bevacizumab will be injected inside ONE keloid tissue to result in a visual expansion of the keloid. Only 1 mg of bevacizumab is injected inside ONE keloid. The injections will be repeated every 14 days. Patients will receive maximum of 12 injections only.~A log will be kept for each patient indicating the date and the dose of bevacizumab that was delivered to each patient.
Study: NCT02484352

Intervention type: DRUG
Group type: OTHER
Intervention: saline
Description: different dosage of IV oxycodone was given before intubation

Intervention type: DRUG
Group type: OTHER
Intervention: 0.05 mg/kg of oxycodone
Description: different dosage of IV oxycodone was given before intubation

Intervention type: DRUG
Group type: OTHER
Intervention: 0.1 mg/kg of oxycodone
Description: different dosage of IV oxycodone was given before intubation

Intervention type: DRUG
Group type: OTHER
Intervention: 0.15 mg/kg of oxycodone
Description: different dosage of IV oxycodone was given before intubation

Intervention type: DRUG
Group type: OTHER
Intervention: 0.2 mg/kg of oxycodone
Description: different dosage of IV oxycodone was given before intubation
Study: NCT02363296

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS
Description: Paired associative stimulation and single pulse TMS
Study: NCT00306527

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cell culture derived influenza vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cell culture derived influenza vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cell culture derived influenza vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Cell culture derived influenza vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: egg-derived influenza subunit vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: egg-derived influenza subunit vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: egg-derived influenza subunit vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: egg-derived influenza subunit vaccine
Description: as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm
Study: NCT02930304

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: first physiotherapy
Description: physiotherapy program consists of cold pack, Transcutaneous electrical nerve stimulation (TENS), and home exercise programme including stretching and eccentric strength exercises will be applied five times a week total 15 sessions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: second physiotherapy
Description: physiotherapy program consists of cold pack, Transcutaneous electrical nerve stimulation (TENS), and home exercise programme including stretching and eccentric strength exercises will be applied five times a week total 15 sessions. Kinesio taping will be applied two times per week total six times in addition to conventional physiotherapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: third physiotherapy
Description: physiotherapy program consists of cold pack, Transcutaneous electrical nerve stimulation (TENS), and home exercise programme including stretching and eccentric strength exercises will be applied five times a week total 15 sessions. Extracorporeal shockwave therapy (ESWT) will be applied one times per week total three session.
Study: NCT03437577

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: immediate-release tacrolimus
Description: Standard of care for transplant patients

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: extended release tacrolimus
Description: Experimental care
Study: NCT04348981

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wearable fitness tracking device
Description: Patients having a wearable fitness tracking device will be monitored for their level of activity after surgery. Declines in activity level will prompt a phone call from the surgical provider.
Study: NCT04369976

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ARTIFICIAL GRAVITY COMBINED WITH EXERCISE
Description: The passive control group will abstain from any exercise. Recordings of the participant's will include cardiovascular functioning cardiac output (CO), stroke volume (SV) mean arterial pressure (MAP) diastolic blood pressure (DBP), systolic blood pressure (SBP), and heart rate (HR), Electroencephalography ( EEG) as well as dynamic force and stance and muscle oxygenation. More specifically, after 6 training sessions (2 weeks), the centrifugation load will be increased and will be combined with either aerobic exercise (through an ergometer) or resistance training through elastic training bands. Functional connectivity and cortical-network features will be used by deep learning algorithms in order to define the optimal centrifuge training .
Study: NCT02767661

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine, 500mg, orally three times daily (continuously)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aromatase Inhibitor
Description: Aromatase Inhibitor (Anastrozole, 1mg, orally once daily or Letrozole, 2.5mg, orally once daily or Exemestane , 25mg, orally once daily)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aromatase Inhibitor
Description: Aromatase Inhibitor (Anastrozole, 1mg, orally once daily or Letrozole, 2.5mg, orally once daily or Exemestane , 25mg, orally once daily)
Study: NCT02144025

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Description: Use of topical cyclosporine (one drop of cyclosporine in each eye, twice a day for 12 months)
Study: NCT00777361

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD3480
Description: Iv single dose, 4-hour infusion of 25 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD3480
Description: Oral solution single dose of 50 mg
Study: NCT02870634

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cu(II)ATSM
Description: copper-containing synthetic small molecule
Study: NCT03131440

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Buddy
Description: Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Study: NCT03365310

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C. longa, curcuminoids , Z. officianale, O. sanctum along with 200 ml of Milk
Description: Polyherbal formulation along with standard of care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care
Description: Usual standard of care for consist of exercise, caloric and protein support, vitamin D, reduction of polypharmacy along with medical management of health condition, assessment of care needs and provision of care. These will be determined on case by case basis by research clinician.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Usual standard of care for consist of exercise, caloric and protein support, vitamin D, reduction of polypharmacy along with medical management of health condition, assessment of care needs and provision of care. These will be determined on case by case basis by research clinician.
Study: NCT04171037

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oxygen Therapy
Description: Receive oxygen via Optiflow THRIVE

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen Therapy
Description: Receive oxygen via non-rebreather

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optiflow THRIVE
Description: Oxygen Administration
Study: NCT02669368

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium Sulfate
Description: Patients in each group receive Magnesium sulfate 30 mg/kg in 0.9% normal saline (total volume 100 ml) intravenously for 5 min before induction of anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: Patients in each group receive 0.9% normal saline (total volume 100 ml) alone intravenously for 5 min before induction of anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: Patients in each group receive 0.9% normal saline (total volume 100 ml) alone intravenously for 5 min before induction of anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard dose Rocuronium
Description: 0.6 mg/kg of Rocuronium given with induction of anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low dose Rocuronium
Description: 0.45 mg/kg of Rocuronium given with induction of anesthesia

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low dose Rocuronium
Description: 0.45 mg/kg of Rocuronium given with induction of anesthesia
Study: NCT03637465

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hydrate Philly
Description: Hydrate Philly is a multi-component intervention that includes water safety testing, provision of 1-2 hydration stations per recreation center, distribution of reusable water bottles for youth, a campaign to promote the acceptability of tap water, and the reduction of access to competing unhealthy beverages through vending machine standards and discouraging black bags (characteristic small, black, plastic bags provided to customers with their corner store purchases, typically including a sugar sweetened beverage and/or unhealthy snack foods).
Study: NCT03615807

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical debridement (if needed)
Description: Surgical debridement

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical debridement (if needed)
Description: Surgical debridement

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Microbiological sampling
Description: Microbiological sampling

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Microbiological sampling
Description: Microbiological sampling

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Revascularisation (if needed).
Description: Revascularisation (if needed).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Revascularisation (if needed).
Description: Revascularisation (if needed).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Off-loading
Description: Off-loading by Special shoes
Study: NCT03306511

Intervention type: OTHER
Intervention: Repeated-sprint test
Description: 6x30-meter sprint interspersed with 90-s rest

Intervention type: OTHER
Intervention: Repeated-sprint test
Description: 6x30-meter sprint interspersed with 90-s rest
Study: NCT03155438

Intervention type: DIAGNOSTIC_TEST
Intervention: Oxidative stress-related gene expression (RNA expression)
Description: Oxidative stress-related gene expression (RNA expression),Superoxide dismutase 1 (SOD1) , SOD2 , Glutathione peroxidase (GPX) and Inducible nitric oxide synthase (iNOS) , measured by Real time PCR technique.

Intervention type: DIAGNOSTIC_TEST
Intervention: Oxidative stress-related gene expression (RNA expression)
Description: Oxidative stress-related gene expression (RNA expression),Superoxide dismutase 1 (SOD1) , SOD2 , Glutathione peroxidase (GPX) and Inducible nitric oxide synthase (iNOS) , measured by Real time PCR technique.

Intervention type: DIAGNOSTIC_TEST
Intervention: oocyte competence biomarkers
Description: Oocyte competence biomarkers ,GDF9, BMP15, Amphiregulin and CoQ10 measured by ELISA

Intervention type: DIAGNOSTIC_TEST
Intervention: oocyte competence biomarkers
Description: Oocyte competence biomarkers ,GDF9, BMP15, Amphiregulin and CoQ10 measured by ELISA
Study: NCT00067379

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: interceptive orthodontic treatments
Description: orthodontic procedures
Study: NCT00321815

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-3512676 + Erlotinib
Description: PF-3512676 0.2 mg/kg subcutaneously on days 1, 8 and 15 of each 21 day cycle until disease progression or unacceptable toxicity.~Erlotinib 150 mg orally daily (21 day cycles) until disease progression or unacceptable toxicity
Study: NCT03615807

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Off-loading
Description: Off-loading by Special shoes

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient's education and instructions
Description: Patient's education and instructions by specialized nurses
Study: NCT00321815

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Erlotinib
Description: Erlotinib 150 mg orally daily (21 day cycles) until disease progression or unacceptable toxicity
Study: NCT04050813

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercises program for hamstring architecture and function
Description: To assess the effectiveness of the inertial flywheel resistance program in the architecture and function of the hamstrings post structural hamstring injury

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercises program for hamstring architecture and function
Description: To assess the effectiveness of the inertial flywheel resistance program in the architecture and function of the hamstrings post structural hamstring injury
Study: NCT03615807

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient's education and instructions
Description: Patient's education and instructions by specialized nurses

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wound debridement
Description: Regular wound debridement by specialized nurses

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wound debridement
Description: Regular wound debridement by specialized nurses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antibiotic duration
Description: Systemic antibiotic duration according to the study arms

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic duration
Description: Systemic antibiotic duration according to the study arms
Study: NCT01262482

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 130 mg/m2, IV during 2 hours on day 1 of each 21 day cycle. Number of cycles: until progression, intolerance or unacceptable toxicity develops, or until patient or investigator decide to stop the treatment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: 400mg, orally, 2 times per day. Until progression, intolerance or unacceptable toxicity develops, or until patient or investigator decide to stop the treatment.